These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3131143)

  • 1. The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen.
    Nieuwenhuizen W; Voskuilen M; Vermond A; Hoegee-de Nobel B; Traas DW
    Eur J Biochem; 1988 May; 174(1):163-9. PubMed ID: 3131143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
    Fischer B
    Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1067-75. PubMed ID: 2128181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.
    Nieuwenhuizen W; Vermond A; Voskuilen M; Traas DW; Verheijen JH
    Biochim Biophys Acta; 1983 Oct; 748(1):86-92. PubMed ID: 6684481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic studies of plasminogen activation by epithelial tissue plasminogen activator.
    Electricwala A; Ling RJ; Atkinson T
    Blood Coagul Fibrinolysis; 1990; 1(1):31-9. PubMed ID: 2129390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains.
    Ries M; Easton RL; Longstaff C; Zenker M; Corran PH; Morris HR; Dell A; Gaffney PJ
    Thromb Res; 2001 Aug; 103(3):173-84. PubMed ID: 11672579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule.
    Urano T; Takada Y; Takada A
    Biochim Biophys Acta; 1991 Apr; 1077(3):245-52. PubMed ID: 1903067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK; Gonias SL
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.
    Watahiki Y; Takada Y; Takada A
    Thromb Res; 1987 Apr; 46(1):9-18. PubMed ID: 3590117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of Glu- and Lys-plasminogens by streptokinase: effects of fibrin, fibrinogen and their degradation products.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1985 Feb; 37(3):465-75. PubMed ID: 3992529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
    Lee PP; Wohl RC; Boreisha IG; Robbins KC
    Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation.
    Beckmann R; Geiger M; Binder BR
    J Biol Chem; 1988 May; 263(15):7176-80. PubMed ID: 2966802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of kinetic parameters of the activation of Glu-plasminogen by tissue plasminogen activator obtained from various sources.
    Takada A; Sugawara Y; Takada Y
    Haemostasis; 1988; 18(2):117-25. PubMed ID: 3137140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators.
    Eastman D; Wurm FM; van Reis R; Higgins DL
    Biochemistry; 1992 Jan; 31(2):419-22. PubMed ID: 1731899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in effects of fibrin(ogen) fragments on the activation of 1-glu-plasminogen and 442-val-plasminogen by tissue-type plasminogen activator.
    Verheijen JH; Nieuwenhuizen W; Traas DW; Chang GT; Hoegee E
    Thromb Res; 1983 Oct; 32(1):87-92. PubMed ID: 6229056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
    Wojta J; Beckmann R; Turcu L; Wagner OF; van Zonneveld AJ; Binder BR
    J Biol Chem; 1989 May; 264(14):7957-61. PubMed ID: 2470738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
    Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
    Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.